Rostock Meeting

Meeting Objective

1The conference was the opening event of the „New INDIGO“-project funded within an In-dian-European framework by the representative national authorities with the aim to estab-lish and expand European-Indian research cooperation. From 29 to 31 January 2014, fortyscientists from six countries met in the context of the first European-Indian Conference in theproject entitled “An attractive and promising strategy for early cancer diagnosis through theassembly of the Human Cancer Volatome - „HCV“.

The conference was organized by the Ger-man project partners, Prof. Jochen Schubert and Dr. Patricia Fuchs, from the Department ofAnesthesiology and Intensive Care Medicine from Rostock University Medical Centre, Ger-many.

New INDIGO platform was launched in the FP7 framework of the European Union to es-tablish funding systems for promotion of Science & Technology (S&T) collaboration betweenIndia and European countries towards the creation of joint infrastructure for advanced re-search.

img
Jochen Schubert addressing first HCV meet.
img
Mass Spectrometer for Human Volatome Analysis
img
Needled Trap Device(NTD) for breathe sampling.
img
Principal Investigator on HCV meeting 1


HCV Project Funding Agencies


The dozens of volatile metabolites identified in both human exhaled breath,saliva,blood and urine, is used to construct a Human Cancer Volatome (HCV) data base.

This can be used to confirm different volatile metabolites as potential cancer biomarkers, to evaluate the risk of cancer development at early stages of the disease, and to monitor the response to cancer treatment.

MEETINGS